Cargando…

A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE

BACKGROUND: The efficacy and safety of thromboprophylaxis in pregnancy at intermediate to high risk of venous thrombo-embolism (VTE) is an area of ongoing research. AIM: This study aimed to assess thrombosis and bleeding outcomes associated with thromboprophylaxis in women at risk of VTE. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schapkaitz, E., Libhaber, E., Gerber, A., Rhemtula, H., Zamparini, J., Jacobson, B.F, Büller, H.R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052495/ https://www.ncbi.nlm.nih.gov/pubmed/36972476 http://dx.doi.org/10.1177/10760296231160748

Ejemplares similares

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
por: Stanciakova, Lucia, et al.
Publicado: (2022)

Risk of Bleeding Associated With Outpatient Use of Rivaroxaban in VTE Management at a National Referral Hospital in Western Kenya
por: Njuguna, Dennis, et al.
Publicado: (2023)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
por: Hussain, Muzamil Hamid, et al.
Publicado: (2023)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis
por: Manoharan, Arumugam, et al.
Publicado: (2022)

Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE
por: Santamaria, Amparo, et al.
Publicado: (2023)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Establishment and Validation of a Postoperative VTE Prediction Model in Patients with Colorectal Cancer Undergoing Radical Resection: CRSPOT Nomogram
por: Wu, Yanan, et al.
Publicado: (2023)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
por: Samuelson Bannow, Bethany, et al.
Publicado: (2021)

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study
por: Scheres, LJJ, et al.
Publicado: (2018)

How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients
por: Costa, Alessandro, et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial)
por: Longo de Oliveira, André Luiz Malavasi, et al.
Publicado: (2022)

Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study
por: Klok, Frederikus A., et al.
Publicado: (2018)

Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Rappaport, Stephen H., et al.
Publicado: (2020)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Factors Affecting Recanalization in Femoropopliteal Deep Vein Thrombosis
por: Erol, Mehmet Emir, et al.
Publicado: (2023)

Perioperative Outcomes of Patients with Bleeding Disorders Undergoing Major Surgery at an Academic Hemophilia Treatment Center
por: Rhoades, Ruben, et al.
Publicado: (2023)

Conservative Management of Overanticoagulation in Patients With Low–Moderate Risk for Bleeding Complications
por: Schapkaitz, Elise, et al.
Publicado: (2018)

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis
por: Spyropoulos, Alex C., et al.
Publicado: (2020)

Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
por: Stevens, Victoria M., et al.
Publicado: (2021)

Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding
por: Al-Attar, Nawwar, et al.
Publicado: (2023)

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis
por: Lipardi, Concetta, et al.
Publicado: (2021)

Silent Pulmonary Embolism in Deep Vein Thrombosis: Relationship and Risk Factors
por: Shi, Yadong, et al.
Publicado: (2022)

Clinical Outcome of Deep Vein Thrombosis Is Related to Thrombophilic Risk Factors
por: Simon, Miriam Anna, et al.
Publicado: (2023)

Transfusion Practices in Gastrointestinal Bleeding – a Tertiary Care Single-Centre Analysis
por: Costa, Ana Palricas, et al.
Publicado: (2022)

Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue
por: Varlas, Valentin Nicolae, et al.
Publicado: (2023)

The Use of Machine Learning Techniques to Predict Deep Vein Thrombosis in Rehabilitation Inpatients
por: Hou, Tingting, et al.
Publicado: (2023)

Attentional conditions differentially affect early, intermediate and late neural responses to fearful and neutral faces
por: Schindler, Sebastian, et al.
Publicado: (2020)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Hepatocyte-derived Microparticles as Novel Biomarkers for the Diagnosis of Deep Venous Thrombosis in Trauma Patients
por: Zang, Xinwei, et al.
Publicado: (2023)

Method combining BAC film and positive staining for the characterization of DNA intermediates by dark-field electron microscopy
por: Benureau, Yann, et al.
Publicado: (2020)

Evaluation of Patient Characteristics Linked to Major Bleeding Events in Patients Prescribed Direct Oral Anticoagulants
por: Kanaan, Dareen M., et al.
Publicado: (2023)

Incidences of deep vein thrombosis and major bleeding under the administration of fondaparinux for thromboprophylaxis after periacetabular osteotomy: a retrospective observational study
por: Fukushima, Kensuke, et al.
Publicado: (2021)

Low Mean Platelet Volume is Associated with Deep Vein Thrombosis in Older Patients with Hip Fracture
por: Wang, Zhicong, et al.
Publicado: (2022)

Correlation Between the Fracture Line Plane and Perioperative Deep Vein Thrombosis in Patients with Tibial Fracture
por: Cai, Xiao, et al.
Publicado: (2021)

Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study
por: Al Harbi, Shmeylan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8uhrohnjaefq1i25spub6t1p8